339 related articles for article (PubMed ID: 18672370)
1. Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone.
Turgeman T; Hagai Y; Huebner K; Jassal DS; Anderson JE; Genin O; Nagler A; Halevy O; Pines M
Neuromuscul Disord; 2008 Nov; 18(11):857-68. PubMed ID: 18672370
[TBL] [Abstract][Full Text] [Related]
2. Halofuginone inhibits Smad3 phosphorylation via the PI3K/Akt and MAPK/ERK pathways in muscle cells: effect on myotube fusion.
Roffe S; Hagai Y; Pines M; Halevy O
Exp Cell Res; 2010 Apr; 316(6):1061-9. PubMed ID: 20060825
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention.
Zion O; Genin O; Kawada N; Yoshizato K; Roffe S; Nagler A; Iovanna JL; Halevy O; Pines M
Pancreas; 2009 May; 38(4):427-35. PubMed ID: 19188864
[TBL] [Abstract][Full Text] [Related]
4. Fibrosis inhibition and muscle histopathology improvement in laminin-alpha2-deficient mice.
Nevo Y; Halevy O; Genin O; Moshe I; Turgeman T; Harel M; Biton E; Reif S; Pines M
Muscle Nerve; 2010 Aug; 42(2):218-29. PubMed ID: 20589893
[TBL] [Abstract][Full Text] [Related]
5. Halofuginone improves muscle-cell survival in muscular dystrophies.
Bodanovsky A; Guttman N; Barzilai-Tutsch H; Genin O; Levy O; Pines M; Halevy O
Biochim Biophys Acta; 2014 Jul; 1843(7):1339-47. PubMed ID: 24703880
[TBL] [Abstract][Full Text] [Related]
6. Halofuginone and muscular dystrophy.
Pines M; Halevy O
Histol Histopathol; 2011 Jan; 26(1):135-46. PubMed ID: 21117034
[TBL] [Abstract][Full Text] [Related]
7. Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone.
Huebner KD; Jassal DS; Halevy O; Pines M; Anderson JE
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1550-61. PubMed ID: 18263710
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of muscle fibrosis and improvement of muscle histopathology in dysferlin knock-out mice treated with halofuginone.
Halevy O; Genin O; Barzilai-Tutsch H; Pima Y; Levi O; Moshe I; Pines M
Histol Histopathol; 2013 Feb; 28(2):211-26. PubMed ID: 23275304
[TBL] [Abstract][Full Text] [Related]
9. Pentoxifylline fails to attenuate fibrosis in dystrophic (mdx) diaphragm muscle.
Gosselin LE; Williams JE
Muscle Nerve; 2006 Jun; 33(6):820-3. PubMed ID: 16502423
[TBL] [Abstract][Full Text] [Related]
10. The involvement of collagen triple helix repeat containing 1 in muscular dystrophies.
Spector I; Zilberstein Y; Lavy A; Genin O; Barzilai-Tutsch H; Bodanovsky A; Halevy O; Pines M
Am J Pathol; 2013 Mar; 182(3):905-16. PubMed ID: 23274062
[TBL] [Abstract][Full Text] [Related]
11. Hydroxy group requirement for halofuginone-dependent inhibition of muscle fibrosis and improvement of histopathology in the mdx mouse model for Duchenne muscular dystrophy.
Wellner G; Mordechay S; Evans P; Genin O; Pines M; Halevy O
Histol Histopathol; 2019 Jul; 34(7):791-801. PubMed ID: 30628720
[TBL] [Abstract][Full Text] [Related]
12. Phenotype of dystrophinopathy in old mdx mice.
Lefaucheur JP; Pastoret C; Sebille A
Anat Rec; 1995 May; 242(1):70-6. PubMed ID: 7604983
[TBL] [Abstract][Full Text] [Related]
13. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy.
Stedman HH; Sweeney HL; Shrager JB; Maguire HC; Panettieri RA; Petrof B; Narusawa M; Leferovich JM; Sladky JT; Kelly AM
Nature; 1991 Aug; 352(6335):536-9. PubMed ID: 1865908
[TBL] [Abstract][Full Text] [Related]
14. Extracts from mdx and normal mouse skeletal muscle contain similar levels of mitogenic activity for myoblasts.
Chen G; Bressler BH; Quinn LS
Cell Biol Int; 1994 Apr; 18(4):229-35. PubMed ID: 8044140
[TBL] [Abstract][Full Text] [Related]
15. Site-dependent pathological differences in smooth muscles and skeletal muscles of the adult mdx mouse.
Boland B; Himpens B; Denef JF; Gillis JM
Muscle Nerve; 1995 Jun; 18(6):649-57. PubMed ID: 7753128
[TBL] [Abstract][Full Text] [Related]
16. Differential calcineurin signalling activity and regeneration efficacy in diaphragm and limb muscles of dystrophic mdx mice.
Stupka N; Michell BJ; Kemp BE; Lynch GS
Neuromuscul Disord; 2006 May; 16(5):337-46. PubMed ID: 16621557
[TBL] [Abstract][Full Text] [Related]
17. A comparison of factors associated with collagen metabolism in different skeletal muscles from dystrophic (mdx) mice: impact of pirfenidone.
Gosselin LE; Williams JE; Personius K; Farkas GA
Muscle Nerve; 2007 Feb; 35(2):208-16. PubMed ID: 17058274
[TBL] [Abstract][Full Text] [Related]
18. Differential Effects of Halofuginone Enantiomers on Muscle Fibrosis and Histopathology in Duchenne Muscular Dystrophy.
Mordechay S; Smullen S; Evans P; Genin O; Pines M; Halevy O
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209117
[TBL] [Abstract][Full Text] [Related]
19. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.
Gibertini S; Zanotti S; Savadori P; Curcio M; Saredi S; Salerno F; Andreetta F; Bernasconi P; Mantegazza R; Mora M
Cell Tissue Res; 2014 May; 356(2):427-43. PubMed ID: 24723230
[TBL] [Abstract][Full Text] [Related]
20. Focusing on fibrosis: halofuginone-induced functional improvement in the mdx mouse model of Duchenne muscular dystrophy.
McLoon LK
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1505-7. PubMed ID: 18310507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
